Medullary Thyroid Cancer Pipeline Analysis Covering Clinical Products and Drugs Involved in Therapeutics
Recent advances in molecular biology resulted in significant improvement in the understanding of the pathogenesis of thyroid carcinoma. In recent years, several targeted therapeutics advances are active in the research field for the treatment of a rare form of thyroid cancer, which is Medullary Thyroid Cancer. Market Research Hub (MRH) has recently announced the addition of a new study, titled "Medullary Thyroid Cancer-Pipeline Insight, 2017" to its massive collection of research reports. This study provides a comprehensive understanding of the...
View full press release